share_log
Reuters ·  Apr 25 06:04
Tandem Diabetes Care Inc : Leerink Partners Raises Target Price to $45 From $34
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment